Up a level |
Cotugno, Nicola, Santilli, Veronica, Pascucci, Giuseppe Rubens, Manno, Emma Concetta, De Armas, Lesley, Pallikkuth, Suresh, Deodati, Annalisa, Amodio, Donato, Zangari, Paola, Zicari, Sonia et al (show 7 more authors)
(2020)
Artificial Intelligence Applied to<i>in vitro</i>Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children.
FRONTIERS IN IMMUNOLOGY, 11.
559590-.
Ruggiero, Alessandra ORCID: 0000-0001-6436-8814, Pascucci, Giuseppe Rubens, Cotugno, Nicola, Dominguez-Rodriguez, Sara, Rinaldi, Stefano, Tagarro, Alfredo, Rojo, Pablo, Foster, Caroline, Bamford, Alasdair, De Rossi, Anita et al (show 15 more authors)
(2022)
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy.
FRONTIERS IN IMMUNOLOGY, 13.
860418-.
Consiglio, Camila Rosat, Cotugno, Nicola, Sardh, Fabian, Pou, Christian, Amodio, Donato, Rodriguez, Lucie, Tan, Ziyang, Zicari, Sonia, Ruggiero, Alessandra ORCID: 0000-0001-6436-8814, Pascucci, Giuseppe Rubens et al (show 13 more authors)
(2020)
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
CELL, 183 (4).
968-+.
Morrocchi, Elena, Pighi, Chiara, Pascucci, Giuseppe Rubens, Cotugno, Nicola, Medri, Chiara, Amodio, Donato, Colagrossi, Luna, Ruggiero, Alessandra ORCID: 0000-0001-6436-8814, Manno, Emma Concetta, Casamento Tumeo, Chiara et al (show 7 more authors)
(2022)
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity<SUP> </SUP>.
CLINICAL INFECTIOUS DISEASES, 75 (SUPPL ).
S51-S60.
Cotugno, Nicola, Ruggiero, Alessandra ORCID: 0000-0001-6436-8814, Bonfante, Francesco, Petrara, Maria Raffaella, Zicari, Sonia, Pascucci, Giuseppe Rubens, Zangari, Paola, De Ioris, Maria Antonietta, Santilli, Veronica, Manno, EC et al (show 12 more authors)
(2021)
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies.
CELL REPORTS, 34 (11).
108852-.